You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Plasma cell mastitis

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Relapsed and/or Refractory Multiple Myeloma, Plasma Cell Leukemia in Relapse Trial in Shanghai (Biological)

Recruiting
  • Relapsed and/or Refractory Multiple Myeloma
  • Plasma Cell Leukemia in Relapse
  • Biological
  • Shanghai, Shanghai, China
    Shanghai Tongji Hospital
May 29, 2023

Multiple Myeloma, Plasma Cell Leukemia Trial in Suzhou (CT0594CP)

Recruiting
  • Multiple Myeloma
  • Plasma Cell Leukemia
  • CT0594CP
  • Suzhou, Jiangsu, China
    First Affiliated Hospital, Soochow University
Apr 18, 2023

Multiple Myeloma, Primary Plasma Cell Leukemia Trial in Shanghai (Experimental: CAR-T cells Infusion)

Not yet recruiting
  • Multiple Myeloma
  • Primary Plasma Cell Leukemia
  • Experimental: CAR-T cells Infusion
  • Shanghai, China
    Shanghai Changzheng Hospital
Apr 20, 2023

Plasma Cell Leukemia Trial in Tianjin (anti-BCMA CAR-T, VRD-based regimen)

Recruiting
  • Plasma Cell Leukemia
  • anti-BCMA CAR-T
  • VRD-based regimen
  • Tianjin, China
    Institute of Hematology and Blood Diseases Hospital Chinese Acad
Aug 4, 2023

Relapsed/Refractory Multiple Myeloma, Plasma Cell Leukemia Trial (CAR-T (CAR-GPRC5D))

Not yet recruiting
  • Relapsed/Refractory Multiple Myeloma
  • Plasma Cell Leukemia
  • CAR-T (CAR-GPRC5D)
  • (no location specified)
Feb 26, 2023

Multiple Myeloma, Plasma Cell Leukemia Trial in Shanghai (Human BCMA targeted CAR-NK cells injection)

Recruiting
  • Multiple Myeloma
  • Plasma Cell Leukemia
  • Human BCMA targeted CAR-NK cells injection
  • Shanghai, Shanghai, China
    Shanghai Changzheng Hospital
Sep 13, 2023

Plasma Cell Leukemia Trial in Tianjin (anti-BCMA CAR-T)

Recruiting
  • Plasma Cell Leukemia
  • anti-BCMA CAR-T
  • Tianjin, China
    Institute of Hematology and Blood Diseases Hospital Chinese Acad
May 13, 2023

Endometrial Cancer Using Plasma Cell-free DNA Fragmentomics

Recruiting
  • Endometrial Cancer
  • low-depth whole-genome sequencing technology
  • Guangzhou, Guangdong, China
    The Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Oct 9, 2023

Multiple Myeloma Trial in Wuhan (SENL103)

Recruiting
  • Multiple Myeloma
  • SENL103
  • Wuhan, Hubei, China
    Tongji Hospital
Sep 27, 2023

COVID-19, Hematopoietic Stem Cell Transplantation Trial in Tianjin (COVID Convalescent Plasma)

Recruiting
  • COVID-19
  • Hematopoietic Stem Cell Transplantation
  • COVID Convalescent Plasma
  • Tianjin, None Selected, China
    Institute of Hematology & Blood Diseases Hospital, Chinese Acade
Jun 13, 2023

Melanoma, NSCLC Trial (Evaluation of ctDNA using the F1T after 1 year of immunotherapy)

Not yet recruiting
  • Melanoma
  • Non-small Cell Lung Cancer
  • Evaluation of ctDNA using the F1T after 1 year of immunotherapy
  • (no location specified)
Nov 24, 2023

Ovarian Cancer Using Plasma Cell-free DNA Fragmentomics

Recruiting
  • Ovarian Cancer
    • Guangzhou, Guangdong, China
      The Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
    Jan 12, 2023

    Ovarian Cancer Using Plasma Cell-free DNA Fragmentomics

    Active, not recruiting
    • Ovarian Cancer
      • Guangzhou, Guangdong, China
        The Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
      Jan 12, 2023

      PLAsma Genomic Testing in Advanced Non-Small Cell Lung Cancer:

      Not yet recruiting
      • Non-small Cell Lung Cancer
      • ctDNA liquid biopsy - Roche Avenio Assay
      • (no location specified)
      Sep 14, 2022

      RRMM, Other Plasma Cell Diseases Trial (LM-305, Dexamethasone)

      Not yet recruiting
      • RRMM
      • Other Plasma Cell Diseases
      • (no location specified)
      Dec 1, 2022

      Relapsed/Refractory Multiple Myeloma, Plasma Cell Leukemia Trial in Wuhan (CAR-T (CAR-GPRC5D))

      Recruiting
      • Relapsed/Refractory Multiple Myeloma
      • Plasma Cell Leukemia
      • CAR-T (CAR-GPRC5D)
      • Wuhan, Hu Bei, China
        Tongji Hospital, Tongji Medical College, Huazhong University of
      May 17, 2022

      Diffuse Large B-cell Lymphoma and High-grade B-cell Lymphoma

      Not yet recruiting
      • Lymphoma, B-Cell
      • +6 more
      • Plasma metabolomic profile by Ultra-high performance liquid chromatography with quadrupole time-of-flight mass spectrometry (UPLC-QTOFMS)
      • Guayaquil, Guayas, Ecuador
        Instituto Oncológico Nacional Dr. Juan Tanca Marengo
      Apr 27, 2023

      Multi-dimensional Fragmentomic Assay for Early Detection of

      Not yet recruiting
      • Pancreatic Neuroendocrine Tumor
      • Fragmentomic profiles of plasma cfDNA
      • (no location specified)
      Apr 27, 2023

      Early Diagnosis of Transplant-associated Thrombotic

      Not yet recruiting
      • Thrombotic Microangiopathies
      • Hematopoietic Stem Cell Transplantation
        • (no location specified)
        Oct 22, 2023

        Management of Plasma Cell Gingivitis by Two Surgical Techniques

        Completed
        • Plasma Cell Gingivitis
        • soft tissue laser
        • Cairo, Egypt
          Ain shams University
        Feb 2, 2022

        Gut Microbiota and Nonpuerperal Mastitis

        Recruiting
        • Microbiota
          • Harbin, Heilongjiang, China
            First affiliated hospital of Harbin medical university
          Sep 9, 2021

          Early Detection of Pancreatic Cancer

          Recruiting
          • Pancreatic Cancer
          • No intervention
          • Tianjin, Tianjin, China
            Tianjin Medical University Cancer Institute and Hospital
          Oct 24, 2022

          Identify Barriers to Cellular Therapies for People With Plasma

          Recruiting
          • Multiple Myeloma
          • Lecture on the role of cellular therapies in relapse/refractory multiple myeloma/RRMM
          • +5 more
          • Basking Ridge, New Jersey
          • +6 more
          Nov 6, 2023

          Plasma NGS for Assessment, Characterization, Evaluation of ALK

          Active, not recruiting
          • Non-Small Cell Lung Cancer
          • Plasma Next Generation Sequencing (NGS)
          • Boston, Massachusetts
            Dana-Farber Cancer Institute
          Jan 26, 2023

          Plasma Cell Leukemia, Plasma Cell Myeloma, Plasmacytoma Trial in Rochester, Nashville (Dexamethasone, Ixazomib Citrate,

          Active, not recruiting
          Has Results
          • Plasma Cell Leukemia
          • +2 more
          • Rochester, Minnesota
          • +1 more
          May 19, 2022